Literature DB >> 17874391

A comparison between clinical and pathologic staging in patients with bladder cancer.

A Mehrsai1, D Mansoori, M Taheri Mahmoudi, A Sina, A Seraji, G H Pourmand.   

Abstract

PURPOSE: To determine the accuracy of clinical staging methods of bladder cancer and TURBT results in estimating the pathologic stage of tumor.
MATERIALS AND METHODS: Thirty two patients who had undergone radical cystectomy were studied in this retrospective survey. The results of bimanual examination, cystoscopy, TURBT pathology report and the tumor contour in CT scan, (size, infiltrative deepness, pelvic lymph nodes involvement and hydronephrosis) were recorded. The type of surgery and pathologic report of cystectomy sample were analyzed as well. Then the results of bimanual examination, tumor size, hydronephrosis and CT scan findings including tumor infiltrative deepness, pelvic lymph adenopathy and TURBT findings were compared to pathologic results of cystectomy sample.
RESULTS: Seven patients were females and 25 were males. Their mean age was 62 (range 36 to 80) years. Gross hematuria and irritative urinary symptoms were the most common complaints. The duration between symptom manifestation and patient's referral was 5 days to 72 months (mean 12 months). Bimanual examination in estimating the extravesical involvement of tumor had a specificity of 82%, sensitivity of 46%, positive predictive value of 70% and negative predictive value of 63%. The size of tumor in determining extravesical involvement had a specificity of 41%, sensitivity of 93%, and positive predictive value of 58% and negative predictive value of 87%. Hydronephrosis was present in 15 patients of whom, 14(93%) had bladder muscle involvement. CT scan specificity was 70%, and sensitivity was 46% regarding pelvic lymph adenopathy and perivesical fat involvement. In TURBT report no muscle sample was observed in 11 cases, so that the interpretations of results were impossible. The reported grade of tumor was lower than pathologic sample of cystectomy in 4 patients.
CONCLUSION: Clinical staging in invasive bladder cancers has not high accuracy regarding the involvement of bladder surrounding fats and pelvic adenopathies. A tumor sized more than 5 cm could be sensitive in estimating extravesical involvement. Positive predictive value of hydronephrosis is considerable regarding bladder muscle involvement. Tumor understaging by TURBT is happened in high percentage of patients with invasive bladder cancer.

Entities:  

Year:  2004        PMID: 17874391

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  13 in total

Review 1.  [Diagnostic procedure for bladder cancer. Standards and current developments].

Authors:  A Karl; S Tritschler; D Zaak; D Tilki; C Stief; M Burger
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

2.  Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.

Authors:  Matthew K Tollefson; Stephen A Boorjian; Sara A Farmer; Igor Frank
Journal:  World J Urol       Date:  2012-03-25       Impact factor: 4.226

3.  Bimanual palpation for staging of bladder cancer-clinical use and its predictors.

Authors:  Lukasz Bialek; Slawomir Poletajew; Piotr Maciej Magusiak; Mikolaj Ostrach; Jakub Szpernalowski; Bartosz Dybowski; Piotr Radziszewski
Journal:  Turk J Urol       Date:  2018-11-21

4.  [Diagnosis of urothelial carcinoma].

Authors:  A Karl; D Zaak; D Tilki; E Hungerhuber; M Staehler; S Denzinger; P Stanislaus; S Tritschler; F Strittmatter; C Stief; M Burger
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

Review 5.  Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer.

Authors:  Wei-Ching Lin; Jeon-Hor Chen
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

6.  Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.

Authors:  Yanchun Wang; Zhen Li; Xiaoyan Meng; Xuemei Hu; Yaqi Shen; John Morelli; Hui Lin; Zhongping Zhang; Daoyu Hu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study.

Authors:  Paweł Grzegółkowski; Krystian Kaczmarek; Artur Lemiński; Michał Soczawa; Adam Gołąb; Marcin Słojewski
Journal:  Cent European J Urol       Date:  2016-12-30

Review 8.  Advances in bladder cancer imaging.

Authors:  Shaista Hafeez; Robert Huddart
Journal:  BMC Med       Date:  2013-04-10       Impact factor: 8.775

9.  Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer - clinical outcome.

Authors:  Jadwiga Nowak-Sadzikowska; Jerzy Jakubowicz; Tomasz Skóra; Katarzyna Pudełek
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28

10.  Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.

Authors:  Hongyi Li; Lin Liu; Qinglei Shi; Alto Stemmer; Hong Zeng; Yi Li; Mengchao Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.